| Application no. and date | 15819519.8 (espacenet) (Federated) (European Patent Register), 20150708 | | Patent/reg. no. and date | DK/EP 3166976, 20220223 | | Publication date | 20170517 | | Priority no. and date | CN 201410325480, 20140709, CN 201410440824, 20140901 | | EP pub. no. and date |
EP 3166976 20170517 | | Effective date | | | Applicant/owner | Birdie Biopharmaceuticals Inc., 4th Floor, Harbour Place
103 South Church Street
P.O. Box 10240
Grand Cayman, KY1-1002, KY | | Applicant ref. no. | P79343DK01 | | Inventor | LI, Lixin, 1-4-13
1 Xiushui Road
Chaoyang
Beijing 100600, CN | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61K 31/4745 (2006.01) , A61K 31/708 (2006.01) , A61K 45/00 (2006.01) , A61K 47/50 (2017.01) , A61P 35/00 (2006.01) | | Title | ANTI-PD-L1-KOMBINATIONER TIL BEHANDLING AF TUMORER | | Int. application no. | CN2015083585 | | Int. publication no. | WO2016004876 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
